首页> 外国专利> INTRODUCTION OF A THIOL GROUP IN PROTEINS FOR RADIOIMUN DETECTION AND RADIOIMMUNTHERAPY BASED ON RADIONUCLIDES

INTRODUCTION OF A THIOL GROUP IN PROTEINS FOR RADIOIMUN DETECTION AND RADIOIMMUNTHERAPY BASED ON RADIONUCLIDES

机译:在基于放射性核素的放射性免疫检测和放射免疫治疗中引入巯基基团

摘要

A method of radiolabeling a protein with a radionuclide including contacting the protein with a protected tertiary thiol-containing bifunctional chelating agent that is capable of reacting with the protein at one end of the agent and is capable of complexing with a radionuclide at the other end of the agent, to form a protein-acetyl-t-thiol-containing conjugate. The protein-acetyl-t-thiol-containing conjugate then is deprotected and admixed with a reducing agent for the radionuclide, where the radionuclide is added in a subsequent step, to form a mixture of reducing agent and protein-t-thiol-containing conjugate. This mixture then is reacted with a radionuclide whereby the radionuclide reacts with pendant sulfhydryl groups present on the protein-t-thiol-containing conjugate. Methods of radioimmunotherapy and diagnostic kits suitable for forming a composition to be administered to a human patient also are disclosed.
机译:一种用放射性核素对蛋白质进行放射性标记的方法,该方法包括使蛋白质与受保护的含叔硫醇的双官能螯合剂接触,该螯合剂能够在试剂的一端与蛋白质反应,并能够与放射性核素的另一端复合。该试剂形成蛋白质-乙酰基-叔硫醇的结合物。然后将含蛋白质-乙酰基-叔硫醇的结合物去保护,并与放射性核素的还原剂混合,然后在后续步骤中加入放射性核素,以形成还原剂和含蛋白质-叔-硫醇的结合物的混合物。 。然后使该混合物与放射性核素反应,从而使放射性核素与存在于含蛋白质-叔硫醇的缀合物上的侧挂巯基反应。还公开了适于形成要施用于人类患者的组合物的放射免疫疗法的方法和诊断试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号